Network Meta-Analysis of Effectiveness of First-Line Immunotherapy Treatments for Patients with Brain Metastases from Advanced Non-Small Cell Lung Cancer

Network Meta-Analysis of Effectiveness of First-Line Immunotherapy Treatments for Patients with Brain Metastases from Advanced Non-Small Cell Lung Cancer

Objective To conduct a network meta-analysis on the effectiveness of first-line immunotherapy on patients with brain metastases from advanced non-small cell lung cancer (NSCLC). Methods Two investigators conducted a computerized search of Pubmed, Embase, Cochrane, and other databases to screen the l...

Full description

Bibliographic Details
Main Authors:	JIA Muyuan, ZHANG Hongjun, LI Lin, WU Jianhui, GONG Huanhuan, REN Bowen, LIU Han
Format:	Article
Language:	zho
Published:	Magazine House of Cancer Research on Prevention and Treatment 2024-05-01
Series:	Zhongliu Fangzhi Yanjiu
Subjects:	non-small cell lung cancer immunotherapy brain metastasis meta-analysis
Online Access:	http://www.zlfzyj.com/en/article/doi/10.3971/j.issn.1000-8578.2024.23.1212

Similar Items

Comparative Efficacy and Safety of Immunotherapy on Non–Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Network Meta‐Analysis
by: Tianyi Lyu, et al.
Published: (2024-08-01)

Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer  with Brain Metastasis
by: Qi SONG, et al.
Published: (2016-08-01)

Progress of Research on Radiotherapy Combined with Immunotherapy for Brain Metastases from Non-small Cell Lung Cancer
by: SUN Yichu, et al.
Published: (2023-07-01)

Development and validation of an MRI-Based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancer
by: Junhao Xu, et al.
Published: (2024-04-01)

A retrospective study of radiotherapy combined with immunotherapy for patients with baseline brain metastases from non-small cell lung cancer
by: Ruoyu Lu, et al.
Published: (2025-02-01)

Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
by: Haiyan Zeng, et al.
Published: (2022-06-01)

PD‐L1 inhibitors combined with whole brain radiotherapy in patients with small cell lung cancer brain metastases: Real‐world evidence
by: Litang Huang, et al.
Published: (2024-04-01)

The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis
by: Xianjing Chu, et al.
Published: (2022-05-01)

Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
by: Zhang Chengkai, et al.
Published: (2023-02-01)

Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060
by: Takehiro Tozuka, MD, et al.
Published: (2024-04-01)

Immunotherapy for brain metastases from non-small cell lung cancer: current status and advances
by: CHEN Xulan, et al.
Published: (2023-06-01)

The role of immunotherapy in patients with lung cancer and brain metastases: a narrative review of the literature
by: Eleni D. Eleftheriadou, et al.
Published: (2024-07-01)

A rare case of bladder cancer that metastasized to brain, heart, and lung lymph nodes benefited from immunotherapy
by: Lian-kai Zhu, et al.
Published: (2022-12-01)

Effect of irinotecan combined with platinum first-line chemotherapy on brain metastasis of small cell lung cancer
by: CHEN Weiling, et al.
Published: (2020-03-01)

Efficacy and Safety of Radiotherapy Combined with Immunotherapy for Brain Metastases from Lung Cancer: A Meta-analysis
by: Lijuan XU, et al.
Published: (2022-10-01)

Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases
by: Thomas Pierret, et al.
Published: (2022-04-01)

Research Progress in the Treatment of Brain Metastases  from Non-small Cell Lung Cancer
by: Xue HAN, et al.
Published: (2020-12-01)

Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer
by: R.F. Yang, et al.
Published: (2017-11-01)

Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy
by: Maria Sereno, et al.
Published: (2024-01-01)

Efficacy and safety of different immunotherapies combined with chemotherapy as first-line therapy in patients with small cell lung cancer: a network meta-analysis
by: Siyao Gong, et al.
Published: (2024-04-01)

Immunotherapy for small-cell lung cancer
by: A. Ye. Kuzminov, et al.
Published: (2019-06-01)

Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain Metastases
by: Judith Porte, et al.
Published: (2022-09-01)

Brain Radiotherapy Combined with Sequential Chemotherapy in Non-Small-Cell Lung Cancer Patients with Brain Metastases
by: Likun CHEN, et al.
Published: (2009-08-01)

Advances in Treatment of Brain Metastases  from Primary Non-small Cell Lung Cancer
by: Gen LIN, et al.
Published: (2014-12-01)

Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort
by: Simon Nannini, et al.
Published: (2024-03-01)

Clinicopathological characteristics and prognosis of synchronous brain metastases from non-small cell lung cancer compared with metachronous brain metastases
by: Jing Li, et al.
Published: (2024-05-01)

The effects of immune checkpoint inhibitors vs. chemotherapy combined with brain radiotherapy in non-small cell lung cancer patients with brain metastases
by: Tengfei Wang, et al.
Published: (2024-10-01)

Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases
by: Mohammed Abdulhaleem, et al.
Published: (2023-11-01)

Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases
by: Justin T. Moyers, et al.
Published: (2021-02-01)

Basis of Tumor Microenvironment Relevant to Immunotherapies for Brain Metastases of NSCLC
by: Qing LAN, et al.
Published: (2019-08-01)

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study
by: Lauren Julia Brown, et al.
Published: (2024-02-01)

Co-Occurrence Conundrum: Brain Metastases from Lung Adenocarcinoma, Radiation Necrosis, and Gliosarcoma
by: David C. Qian, et al.
Published: (2021-03-01)

Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060)
by: Meichen Li, et al.
Published: (2022-12-01)

Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors
by: Ryul Kim, et al.
Published: (2019-01-01)

Sex difference in response to non-small cell lung cancer immunotherapy: an updated meta-analysis
by: Jiali Liang, et al.
Published: (2022-12-01)

Progress of Immunotherapy Mechanisms and Current Evidence of PD-1/PD-L1  Checkpoint Inhibitors for Non-small Cell Lung Cancer with Brain Metastasis
by: Jiamin SHENG, et al.
Published: (2020-11-01)

Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
by: Wei Zhao, et al.
Published: (2022-11-01)

The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastases
by: Cole Billena, et al.
Published: (2023-02-01)

The Role of the Immune Response in Brain Metastases: Novel Imaging Biomarkers for Immunotherapy
by: Rasheed Zakaria, et al.
Published: (2021-10-01)

Clinical Experience of Gefitinib in the Treatment of 32 Lung Adenocarcinoma Patients with Brain Metastases
by: Jianping XU, et al.
Published: (2015-09-01)